XOM

ExxonMobil

$164.73

-0.69%
Nov 9, 2026
Bobby Quantitative Model
ExxonMobil is the world's largest publicly traded integrated oil and gas company, spanning upstream exploration and production (3.3 million barrels of liquids and 8.4 billion cubic feet of gas per day in 2025), downstream refining (4.1 million barrels per day of global capacity), and a large commodity and specialty chemicals business, backed by 19.3 billion barrels of oil equivalent in reserves. Its scale, integrated model, and low-cost Guyana and Permian growth assets give it a distinct position as the sector's balance-sheet anchor and dividend aristocrat rather than a pure-play price taker. The current investor debate centers on an unusually strong 2026 earnings cycle — Q3 revenue up 32.6% year over year with EPS of $3.72 versus $1.76 a year earlier — driven by refining margins and upstream volumes, which has pushed the stock up roughly 45% over twelve months even as the broader market has been flat. Offsetting that enthusiasm is a sharp late-October pullback tied to Middle East de-escalation headlines (a U.S.-Iran deal reopening Hormuz sank oil prices), leaving investors to weigh whether the earnings surge is a durable structural improvement or a cyclical peak now being discounted.

People also watch

Chevron Corporation

Chevron Corporation

CVX

Analysis
National Fuel Gas

National Fuel Gas

NFG

Analysis
ConocoPhillips

ConocoPhillips

COP

Analysis
Marathon Petroleum

Marathon Petroleum

MPC

Analysis
Phillips 66

Phillips 66

PSX

Analysis

BobbyInvestment Opinion: Should I buy XOM Today?

Rating: Hold with a constructive lean. The core thesis is that ExxonMobil's Q3 2026 earnings surge — EPS of $3.72 versus $1.76 a year earlier and revenue up 32.61% to $110.50 billion — is real and well-funded, but the stock at $165.87 already sits within 11.6% of the $185.05 average analyst target after a 44.86% twelve-month run, leaving limited reward relative to commodity-driven downside. The 2.42 recommendation mean (9 Buy, 17 Hold, 0 Sell) accurately captures this: the company is executing, but the Street sees fair value close to current levels.

The supporting evidence is genuinely strong. Forward PE of 13.33x against trailing 17.96x implies roughly 26% earnings growth to the $9.93 consensus EPS, and EV/EBITDA of 8.12x is in line with large-cap integrated peers rather than at a premium. Trailing free cash flow of $42.96 billion comfortably covers the 3.33% dividend (59.7% payout ratio) plus $5.10 billion of quarterly buybacks, while debt-to-equity of 0.168 and a current ratio of 1.153 mean there is no balance-sheet constraint on the story. Relative strength of +35.27 versus SPY over twelve months confirms this is leadership, not a value trap — but gross margin has already fallen from 37.71% in Q1 to 24.13% in Q3, and the 2027 revenue estimate band of $331.4B–$452.4B (a 36% spread) shows how much of the earnings base remains a commodity bet.

The risks that would invalidate the thesis are margin normalization, geopolitical de-escalation, and a full multiple. If refining cracks revert toward 2025 norms and Q4 EPS falls short of the $9.93 consensus, the trailing 17.96x multiple — above the 13–16x band of 2023–2025 — would compress toward 13x forward, which is roughly where the $160 low analyst target sits. This Hold would upgrade to Buy on a pullback toward the $150–$160 support shelf (implying ~15–17% upside to the $185.05 average target) or on evidence that Q4 gross margin holds above 24%; it would downgrade to Sell on a decisive break below $160 combined with a cut to 2027 EPS estimates. Verdict: fairly valued to modestly full — not overvalued relative to forward earnings, but no longer cheap after a 45% run.

Sign up to view all

XOM 12-Month Price Forecast

ExxonMobil enters the next twelve months as a high-quality integrated major whose earnings have inflected sharply but whose share price has already traveled 44.86% in a year to within 11.6% of the consensus target. The valuation is full rather than stretched — 13.33x forward earnings and 8.12x EV/EBITDA are reasonable for a company generating $42.96 billion of free cash flow with negligible leverage — but the 17.96x trailing multiple leaves little cushion if refining margins normalize faster than the $9.93 consensus EPS assumes. Analyst sentiment is constructive but not urgent: 9 Buys against 17 Holds, a 2.42 recommendation mean, and a $160–$213 target range that is 33% wide, reflecting uncertainty about crude and cracks rather than about the franchise. The most likely path is consolidation and a grind toward the $185 average target, with the $160–$162 shelf as the line in the sand. I would upgrade to bullish on a confirmed hold of Q4 gross margin above 24% or a pullback toward $150 that restores 20%+ upside to target, and downgrade to bearish on a decisive break below $160 paired with 2027 EPS estimate cuts.

Historical Price
Current Price $164.73
Average Target $182.50
High Target $213.00
Low Target $140.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on ExxonMobil's 12-month outlook, with a consensus price target around $185.05 and implied upside of +12.3% versus the current price.

Average Target

$185.05

26 analysts

Implied Upside

+12.3%

vs. current price

Analyst Count

26

covering this stock

Price Range

$160 - $213

Analyst target range

Buy
9 (35%)
Hold
17 (65%)
Sell
0 (0%)

Coverage is deep, with 22 analysts and a distribution of 9 Buy, 17 Hold, and 0 Sell — a neutral-to-constructive consensus reflected in a recommendation mean of 2.42 (Hold/Buy boundary) despite the headline "buy" label. The average target price of $185.05 implies roughly +11.6% upside from the current $165.87, and notably sits almost exactly at the October closing high of $187.25, suggesting the Street views the recent spike as fair value rather than overextension. Consensus 2027 EPS of $9.93 and revenue of $394.7 billion underpin that target, and the bullish tilt is reinforced by recent reiterations from Morgan Stanley (Overweight), UBS (Buy), TD Cowen (Buy), Evercore (Outperform), and Barclays (Overweight).

The target range of $160.00 to $213.00 is moderately wide — a 33% spread from low to high — signaling meaningful uncertainty about oil and refining margins rather than about the company itself. The $213 high target implies roughly 28% upside and would require sustained elevated refining cracks, continued Guyana and Permian volume growth, and multiple expansion toward 15x forward earnings; the $160 low target sits essentially at the current price and prices in margin normalization and softer crude. The most notable signal is the October 1 downgrade of Wells Fargo from Overweight to Equal Weight, the only negative action in the recent tape, which aligns with the post-October consolidation — overall, analyst conviction is intact but the marginal revision trend has turned cautious, consistent with a stock that has already captured much of its near-term upside.

Drowning in data?

Find the real signal!

Bulls vs Bears: XOM Investment Factors

The bull case currently has stronger evidence: Q3 EPS of $3.72 versus $1.76 a year ago, 32.6% revenue growth, $42.96 billion of trailing FCF, a 0.168 debt-to-equity ratio, and a forward PE of 13.3x against a $185.05 average target (+11.6%) form a coherent, data-backed thesis. The bear case rests less on fundamentals than on timing — gross margins have already compressed from 37.71% in Q1 to 24.13% in Q3, the stock has given back 11.4% in under a week on Middle East de-escalation, and the 2.42 recommendation mean with 17 Holds signals the Street sees fair value near current levels. The single most important tension is whether the 2026 refining-margin and upstream-volume surge is a durable structural improvement or a cyclical peak now being discounted — if Q4 margins hold near Q3 levels the forward PE of 13.3x is cheap, but if cracks revert toward 2025 norms the trailing 17.96x multiple is full. The $160–$162 technical shelf and the $160 low analyst target converge as the line in the sand: holding that level keeps the uptrend intact, while a decisive break would validate the cyclical-peak interpretation.

Bullish

  • Q3 earnings nearly doubled YoY: Q3 2026 diluted EPS of $3.72 versus $1.76 a year earlier, with net income of $15.41 billion against $7.55 billion — a 104% increase. Revenue of $110.50 billion grew 32.61% YoY, demonstrating powerful operating leverage on the refining-margin and upstream-volume surge.
  • Fortress balance sheet, minimal leverage: Debt-to-equity of just 0.168 and a current ratio of 1.153 leave ExxonMobil with essentially no financial strain. Q3 operating cash flow of $25.65 billion covered $7.18 billion of capex, $4.26 billion of dividends, $5.10 billion of buybacks, and still allowed $7.50 billion of debt repayment.
  • Forward PE compresses to 13.3x: The stock trades at 17.96x trailing but only 13.33x forward earnings, a ~26% compression that reflects consensus EPS of $9.93 versus the trailing run-rate. EV/EBITDA of 8.12x is broadly in line with large-cap integrated peers, so the premium trailing multiple is not extreme on a forward basis.
  • Analyst targets imply +11.6% upside: The $185.05 average target sits ~11.6% above the $165.87 current price and almost exactly at the October closing high of $187.25, with a high target of $213 (+28%). Nine Buy ratings versus zero Sells and reiterations from Morgan Stanley, UBS, TD Cowen, Evercore, and Barclays support the constructive tilt.

Bearish

  • Refining margins already normalizing: Gross margin fell from 37.71% in Q1 to 22.38% in Q2 and 24.13% in Q3, showing the unusually strong Q1 refining spreads have faded. If cracks continue to normalize, the earnings surge that drove the 45% twelve-month rally may prove cyclical rather than structural.
  • Sharp 11.4% drawdown in one week: The stock slid from $187.25 on October 30 to $165.87 on November 6 after the U.S.-Iran deal reopened Hormuz and crude fell 5% in a day. Volume of ~15.9 million shares suggests the selloff has not reached capitulation, leaving further downside risk toward the $160–$162 support shelf.
  • Consensus is Hold, not Buy: Despite the headline 'buy' label, the recommendation mean of 2.42 sits at the Hold/Buy boundary with 17 Holds versus 9 Buys across 22 analysts. Wells Fargo's October 1 downgrade from Overweight to Equal Weight was the marginal revision signal, consistent with a stock that has captured most near-term upside.
  • Valuation full versus history: At 17.96x trailing PE, XOM sits in the middle-to-upper portion of its historical band and well above the 13–16x levels seen through most of 2023–2025. The 1.82x EV/sales is a premium to the sector's high-single-to-low-double-digit typical multiples, leaving little room for disappointment.

XOM Technical Analysis

ExxonMobil is in a powerful, sustained uptrend: the stock is up 44.86% over the past year and 35.24% year to date, dramatically outperforming the S&P 500's 9.59% and 7.83% respective returns. At $165.87, the shares sit at roughly 69.7% of the 52-week range of $114.19 to $188.50 — closer to the highs than the midpoint, but notably about 12% below the October peak of $187.25, meaning momentum has cooled from an overextended state into a high-level consolidation rather than a breakdown. The relative strength readings confirm persistent leadership, with a 1-year relative strength of +35.27 versus SPY.

Short-term momentum has decelerated sharply even as the medium-term trend remains intact: the stock is up just 1.11% over the past month and 8.38% over three months, a marked slowdown from the 14.73% six-month gain. The last five sessions tell the story — a slide from $187.25 on October 30 to $165.87 on November 6, a roughly 11.4% drawdown in under a week, coinciding with the Hormuz reopening news and a 5% one-day drop in crude. Notably, the 1-month relative strength versus SPY is still +6.10 because the market itself fell 4.99% over the same period, so XOM is declining from a position of relative strength rather than absolute weakness. Volume of about 15.9 million shares on the latest session is unremarkable, suggesting the selloff has not yet reached capitulation levels.

Key technical levels are well defined: immediate support sits at the $160–$162 shelf that held through September and again in early November, with the 52-week low of $114.19 as the deeper structural floor, while resistance is the October high of $188.50, just above the $187.25 closing peak. A reclaim of $175–$180 would signal the pullback was a shakeout and re-open the path to new highs; a decisive break below $160 would target the $150 area where the stock consolidated in May and July. The reported beta of 0.141 is anomalously low for an integrated oil major and likely reflects a data artifact or a very short measurement window — investors should treat XOM's true market sensitivity as closer to 0.8–1.0 and size positions accordingly, especially given the 20.65% maximum drawdown already recorded this year.

Beta

0.14

0.14x market volatility

Max Drawdown

-20.6%

Largest decline past year

52-Week Range

$114-$189

Price range past year

Annual Return

+40.5%

Cumulative gain past year

PeriodXOM ReturnS&P 500
1m-2.5%-3.3%
3m+3.1%-2.3%
6m+8.7%+1.4%
1y+40.5%+12.2%
ytd+34.3%+10.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

XOM Fundamental Analysis

The revenue trajectory has inflected sharply upward: Q3 2026 revenue of $110.50 billion grew 32.61% year over year versus $83.33 billion in Q3 2025, and rose sequentially from $114.53 billion in Q2 and $83.16 billion in Q1. The quarterly progression — $83.16B, $114.53B, $110.50B — shows a step-change beginning in Q2, consistent with the refining-margin and upstream-volume strength highlighted in peer results, and the Q3 print included $1.13 billion of income from equity affiliates plus $1.54 billion of other revenue on top of $110.50 billion of sales and other operating revenue. With consensus 2027 revenue estimated at $394.7 billion (range $331.4B–$452.4B), the growth trend supports the investment case, but the wide estimate band underscores how commodity-price dependent the top line remains.

Profitability is robust and improving: Q3 net income reached $15.41 billion (a 13.95% net margin) on $26.66 billion of gross profit (24.13% gross margin), up from $7.55 billion and a 22.42% gross margin in the year-ago quarter. The sequential margin path — 37.71% gross in Q1, 22.38% in Q2, 24.13% in Q3 — reflects normalizing refining spreads after an unusually strong Q1, while operating margin held at 16.98% and EBITDA margin at 25.54% in Q3. Trailing net margin of 8.91% and operating margin of 10.48% are healthy for an integrated major, and the $3.72 quarterly diluted EPS versus $1.76 a year ago demonstrates meaningful operating leverage on the revenue surge.

Financial health is a clear strength: debt-to-equity of just 0.168, a current ratio of 1.153, and trailing free cash flow of $42.96 billion give ExxonMobil ample internal funding capacity. Q3 operating cash flow of $25.65 billion comfortably covered $7.18 billion of capex (FCF of $18.47 billion), $4.26 billion of dividends, and $5.10 billion of buybacks, with $7.50 billion of debt repaid on top. ROE of 11.12% and ROA of 6.75% are solid but not exceptional for the sector, and the 3.33% dividend yield with a 59.7% payout ratio is well covered by the $42.96 billion FCF base — the balance sheet poses minimal financial risk, leaving commodity prices as the dominant variable.

Quarterly Revenue

$110.5B

2026-09

Revenue YoY Growth

+32.6%

YoY Comparison

Gross Margin

24.1%

Latest Quarter

Free Cash Flow

$43.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Sales and Other Operating Revenue
Income From Equity Affiliates
Other Revenue

Open an Account, get $2 TSLA now!

Valuation Analysis: Is XOM Overvalued?

Because ExxonMobil is solidly profitable (Q3 net income of $15.41 billion), the PE ratio is the appropriate primary metric. The stock trades at 17.96x trailing earnings but only 13.33x forward earnings — a roughly 26% compression that implies the market expects earnings to grow meaningfully, consistent with consensus EPS of $9.93 versus the trailing run-rate. The negative PEG ratio of -1.24 is a mechanical artifact of historical earnings volatility and should be disregarded; the forward PE of 13.3x is the more decision-relevant figure.

Against the integrated oil and gas peer group, XOM's 17.96x trailing PE and 1.82x EV/sales sit at a premium to the sector's typical high-single-to-low-double-digit multiples, while its 8.12x EV/EBITDA is broadly in line with large-cap integrated peers. The 2.00x price-to-book and 1.60x price-to-sales are modest in absolute terms, and the 3.33% dividend yield is above the sector average, offering income support. The premium is defensible given ExxonMobil's scale, low 0.168 debt-to-equity, and $42.96 billion FCF generation, but it leaves less room for disappointment if refining margins normalize.

Historically, XOM's PE has ranged from roughly 8.8x (Q4 2022) to 42.4x (Q1 2026, a seasonally weak quarter), with the 17.96x current reading near the middle-to-upper portion of that band and well above the 13–16x levels seen through most of 2023–2025. The price-to-sales ratio of 1.60x is near the low end of its historical range (which peaked above 8x in Q1 2026 on depressed quarterly revenue), while price-to-book of 2.00x is mid-range versus the 1.55x–2.79x band of the past four years. The market is pricing in optimistic but not extreme expectations — the valuation is full rather than stretched, and the recent 11% pullback has modestly improved the entry point.

PE

18.0x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 5x~20x

vs. Industry Avg

15.5x

Industry PE ~15.5x*

EV/EBITDA

8.1x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are modest but real. The 0.168 debt-to-equity ratio and $42.96 billion trailing FCF mean solvency is not a concern, but earnings quality is highly commodity-dependent: gross margin swung from 37.71% in Q1 to 22.38% in Q2 and 24.13% in Q3, and net margin ranged from 5.03% in Q1 to 13.95% in Q3 within the same year. Revenue is concentrated in upstream and refining, where Q3's $110.50 billion top line benefited from elevated cracks that are already normalizing, and the 36% spread in 2027 revenue estimates ($331.4B–$452.4B) quantifies how wide the earnings outcome band remains. The 59.7% payout ratio is covered by FCF today, but a sustained margin downturn would pressure the dividend-growth streak that income investors rely on.

Market and competitive risks center on valuation compression and sector rotation. At 17.96x trailing PE — above the 13–16x band of 2023–2025 — and 1.82x EV/sales versus typical high-single-to-low-double-digit sector multiples, XOM carries a premium that assumes continued earnings strength; a re-rating toward historical mid-range multiples would erase much of the $185.05 average target's implied upside. The reported beta of 0.141 is an artifact and should be treated as closer to 0.8–1.0, meaning XOM is not the defensive hedge its beta implies. The June 15 U.S.-Iran deal reopening Hormuz triggered a 5% one-day crude drop and an 11.4% XOM drawdown in under a week, illustrating how quickly geopolitical de-escalation can rotate capital out of energy; Wells Fargo's October 1 downgrade to Equal Weight shows the marginal analyst revision trend has already turned cautious.

In a worst-case scenario, sustained Middle East de-escalation pushes Brent lower, refining cracks revert toward 2025 norms, and Q4 EPS falls well short of the $9.93 consensus, forcing analysts to cut targets and the multiple to compress toward 13x forward. The stock has already recorded a 20.65% maximum drawdown this year, and a break below the $160–$162 support shelf would target the $150 consolidation area from May and July — roughly -9.6% from $165.87. A fuller normalization toward the $114.19 52-week low would represent a -31% loss, though that would require a severe crude collapse; the more realistic adverse case is the $160 low analyst target, essentially flat, or the $150 technical zone, about -10%.

FAQ

The most severe risk is commodity and margin normalization: gross margin already fell from 37.71% in Q1 to 22.38% in Q2 and 24.13% in Q3, and if refining cracks revert toward 2025 norms, the earnings surge underpinning the 13.33x forward multiple disappears. Second is valuation compression — at 17.96x trailing, above the 13–16x band of 2023–2025, a re-rating toward historical mid-range multiples would erase most of the implied upside to the $185.05 target. Third is geopolitical and macro reversal: the June 15 U.S.-Iran deal reopening Hormuz triggered a 5% one-day crude drop and an 11.4% XOM drawdown in under a week, and the reported 0.141 beta understates true market sensitivity, which is closer to 0.8–1.0. Fourth is estimate and sentiment risk — consensus 2027 revenue spans $331.4B to $452.4B (a 36% range), and Wells Fargo's October 1 downgrade to Equal Weight shows the marginal analyst revision trend has already turned cautious, with 17 Holds against 9 Buys.

The base case carries 50% probability with a $175–$190 target range, assuming 2027 revenue near the $394.7 billion consensus, gross margin stabilizing in the low-to-mid 20s, and a forward PE holding at 13–14x — a path that converges on the $185.05 average analyst target, about +11.6% from $165.87. The bull case at 25% probability targets $195–$213, requiring Q4 gross margin at or above Q3's 24.13%, continued Guyana and Permian volume growth, and Brent recovering above $80, with the $213 high analyst target implying roughly +28%. The bear case at 25% probability targets $140–$160, driven by durable Middle East de-escalation, faster crack normalization, and analyst downgrades compressing the multiple below 13x forward. The base case is most likely because it requires only that current trends persist rather than accelerate, and its key assumption is that refining margins normalize gradually rather than collapse.

XOM looks fairly valued to modestly full rather than clearly cheap or expensive. The primary metric is the PE ratio given solid profitability: 17.96x trailing but only 13.33x forward, a roughly 26% compression that reflects consensus EPS of $9.93 versus the trailing run-rate. That forward multiple is reasonable for an integrated major, and EV/EBITDA of 8.12x is broadly in line with large-cap peers, but the trailing 17.96x sits above the 13–16x band the stock held through most of 2023–2025, and 1.82x EV/sales is a premium to the sector's typical high-single-to-low-double-digit multiples. Price-to-book of 2.00x and price-to-sales of 1.60x are mid-range versus the past four years, and the negative PEG of -1.24 is a mechanical artifact of earnings volatility that should be ignored. The market is pricing in continued earnings strength rather than a cyclical peak — optimistic but not extreme, and the recent 11% pullback has modestly improved the entry point.

From a risk/reward standpoint XOM is reasonable but not compelling at $165.87. The $185.05 average analyst target implies only about +11.6% upside, and that target sits almost exactly at the October closing high of $187.25, so the Street is effectively saying the recent spike was fair value rather than an overshoot. The downside is more open-ended: the $160 low target is essentially flat to today, and a break of the $160–$162 shelf would target the $150 area, roughly -10%. Against that, the fundamentals are genuinely strong — Q3 EPS of $3.72 versus $1.76 a year earlier, $42.96 billion of trailing free cash flow, 0.168 debt-to-equity, and a 3.33% dividend covered at a 59.7% payout ratio. It is a good buy for income-oriented, patient investors who want energy exposure and can tolerate commodity swings, particularly on a pullback toward $150–$160 that restores 15–17% upside to target; it is less attractive for investors chasing near-term capital gains after a 44.86% twelve-month run.

XOM is better suited to long-term holding than short-term trading. It is a mature, capital-intensive integrated major with a 43-year dividend growth streak, a 3.33% yield covered at a 59.7% payout ratio, and $42.96 billion of trailing free cash flow — characteristics that reward patience rather than momentum chasing. Short-term traders face a difficult setup: the stock has already run 44.86% in twelve months and 35.24% year to date, then gave back 11.4% in under a week in early November, and the 20.65% maximum drawdown recorded this year shows how quickly commodity headlines can move it. Earnings visibility is also limited by commodity prices, with 2027 revenue estimates spanning a 36% range. A reasonable minimum holding period is 18–24 months, long enough to collect roughly two years of dividends and to let the refining-margin cycle and Guyana/Permian volume growth play out, with position sizing that accounts for true market sensitivity closer to 0.8–1.0 rather than the reported 0.141 beta.